Trial Profile
An Open Label Study to Evaluate the Pharmacokinetics of ASP3652 After a Single Oral Dose of 14C-labeled ASP3652 in Healthy Caucasian Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Jun 2014
Price :
$35
*
At a glance
- Drugs ASP 3652 (Primary)
- Indications Interstitial cystitis
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 17 Feb 2014 New trial record